Intelligencer | Wheeling Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk Northern Panhandle • Nov 9, 2025
WVNews | Business Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk West Virginia Business • Nov 9, 2025
Times West Virginian | Fairmont Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump Mountaineer Country • Sep 30, 2025
News and Sentinel | Parkersburg Pfizer agrees to lower drug costs, others may, too, president says Mid-Ohio Valley • Sep 30, 2025
WVNews | Business Pfizer ends development of potential pill obesity treatment West Virginia Business • Apr 14, 2025
WCHS Charleston West Virginia sues Pfizer, Ranbaxy in antitrust lawsuit for over $15 million Metro Valley • Dec 16, 2024
Intelligencer | Wheeling Tornado damage to Pfizer plant will probably create long-term shortages of some drugs hospitals need Northern Panhandle • Jul 20, 2023
Bluefield Daily Telegraph Tornado damages Pfizer plant in North Carolina as scorching heat and floods sock other parts of US New River & Greenbrier Valley • Jul 20, 2023
Gazette Mail | Charleston Pfizer buys Seagen for $43B, boosts access to cancer drugs Metro Valley • Mar 13, 2023
WVNews | Business Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference West Virginia Business • Nov 11, 2022
Herald Dispatch | Huntington Pfizer says COVID-19 vaccine will cost $110-$130 per dose Metro Valley • Oct 21, 2022
Gazette Mail | Charleston Pfizer wants 5- to 11-year-olds to take omicron booster Metro Valley • Sep 27, 2022
News and Sentinel | Parkersburg Pfizer seeks to expand omicron booster to 5- to 11-year-olds Mid-Ohio Valley • Sep 26, 2022
Intelligencer | Wheeling Pfizer seeks to expand omicron booster to 5- to 11-year-olds Northern Panhandle • Sep 26, 2022
News and Sentinel | Parkersburg Moderna sues Pfizer over patents behind COVID-19 vaccine Mid-Ohio Valley • Aug 26, 2022
Gazette Mail | Charleston Moderna sues Pfizer over patents behind COVID-19 vaccine Metro Valley • Aug 26, 2022
WVNews | Business Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine West Virginia Business • Aug 26, 2022
WVNews | Business Pfizer Announces Positive Top-Line Data from Phase 3 Trial of Older Adults for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate West Virginia Business • Aug 25, 2022
Herald Dispatch | Huntington Pfizer COVID shots appear 73% effective in children under 5 Metro Valley • Aug 23, 2022
WVNews | Business Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine West Virginia Business • Aug 22, 2022
WVNews | Business Global Hemophilia Treatment Market Report to 2027 - Players Include Medexus Pharmaceuticals, Novo Nordisk, Octapharma and Pfizer - ResearchAndMarkets.com West Virginia Business • Aug 17, 2022
WVNews | Business Elderly Nutrition Market Research Report 2022: Featuring Key Players Abbott, Danone, Pfizer, Nestle & Others - ResearchAndMarkets.com West Virginia Business • Aug 17, 2022
WVNews | Business Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15 West Virginia Business • Aug 8, 2022
WVNews | Business $964 Billion Worldwide Biotechnology Industry to 2027 - Featuring Amgen, Biogen, Novartis and Pfizer Among Others - ResearchAndMarkets.com West Virginia Business • Aug 3, 2022